IP Library Granted Patent US 12,515,042
Granted Patent B2
US 12,515,042 · App. 18/447,504 · Granted Jan 6, 2026

Pacing guidewire

Inventors: David Daniels (Petaluma, CA); Chad Kugler (Buffalo, MN); John Bridgeman (Minneapolis, MN); Derek Stratton (Minneapolis, MN); Dean Peterson (Minneapolis, MN); Joshua Brenizer (Oak Grove, MN)
Assignee: Teleflex Life Sciences LLC
A61N1/056A61M25/09A61N1/36507A61N1/36564A61N1/3752A61B5/287A61B5/6851A61N1/375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,515,042
App. No.
18/447,504
Granted
Jan 6, 2026
Kind
B2
Abstract

Guidewires and methods for transmitting electrical stimuli to a heart and for guiding and supporting the delivery of elongate treatment devices within the heart are disclosed. A guidewire can comprise an elongate body, including first and second elongate conductors, and at least first and second electrodes. A distal end portion of the elongate body can include a preformed bias shape, such as a pigtail-shaped region, on which the first and second electrodes can be located. The preformed bias shape can optionally be non-coplanar relative to an intermediate portion of the elongate body. The first and second elongate conductors can be formed of a single structure or two or more electrically connected structures. The conductors can extend from proximal end portions to distal end portions that electrically connect to the first and second electrodes. A corewire can extend the length of the elongate body, can at least partially form the first conductor, and can be at least partially surrounded by the second conductor.

Claims (35)

1 . A system comprising:

an elongated body extending from a proximal end portion to a distal end portion and having an intermediate portion therebetween, the distal end portion including an electrode configured to be positioned on or spaced from a ventricular wall of a heart of a patient;

an electrical pulse generator configured to deliver electrical stimulation to the electrode via the guidewire, wherein the electrical pulse generator is further configured to;

detect an electrophysiological output from the heart, via conduction of the electrophysiological output through the electrode in response to delivery of the electrical stimulation, and based on the detected electrophysiological response, to adjust a characteristic of the electrical stimulation to achieve or maintain rapid pacing of the heart, wherein the proximal end portion and the intermediate portion are configured to support delivery and accurate positioning placement of a treatment device to the heart while the electrical pulse generator maintains the rapid pacing of the heart.

2 . The system of claim 1 , wherein the electrical pulse generator is further configured to, based on a pulse pressure and/or a systolic blood pressure, adjust the characteristic of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

3 . The method of claim 1 , wherein the electrical pulse generator is further configured to detect the pulse pressure and/or the systolic blood pressure via a pressure monitor positioned in a central artery of the patient.

4 . The system of claim 1 , wherein the electrical pulse generator is further configured to, based on a heart rate included in the electrophysiological response, adjust the characteristic of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

5 . The system of claim 4 , wherein the electrical pulse generator is further configured to detect the heart rate of the patient.

6 . The system of claim 1 , wherein the electrical pulse generator is further configured to, based on the detected electrophysiological response, adjust a pacing rate of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

7 . The system of claim 1 , wherein the electrical pulse generator is further configured to, based on the detected electrophysiological response, adjust the pacing rate of the electrical stimulation to achieve or maintain to drop a blood pressure or a cardiac output of the heart of the patient below a threshold amount.

8 . The system of claim 7 , wherein the electrical pulse generator is further configured to set the threshold amount of the blood pressure of the cardiac output to facilitate safe balloon deployment to the heart.

9 . An apparatus comprising:

a guidewire extending from a proximal end portion to a distal end portion and having an intermediate portion therebetween, the distal end portion including an electrode;

electronic circuitry having instructions configured to cause the electronic circuitry to:

deliver, via an electrical pulse generator, electrical stimulation through the guidewire to the electrode positioned on or spaced from a ventricular wall of a heart of a patient;

detect, at the electrical pulse generator, an electrophysiological response in response to delivery of the electrical stimulation; and

based on the detected electrophysiological response, adjust a characteristic of the electrical stimulation to achieve or maintain rapid pacing of the heart, wherein the proximal end portion and the intermediate portion are configured to support delivery and accurate positioning placement of a treatment device to the heart while the electronic circuitry maintains rapid pacing of the heart.

10 . The apparatus of claim 9 , wherein the instructions are further configured to cause the electronic circuitry to, based on a pulse pressure and/or a systolic blood pressure, adjust the characteristic of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

11 . The apparatus of claim 10 , wherein the instructions are further configured to cause the electronic circuitry to detect the pulse pressure and/or the systolic blood pressure via a pressure monitor positioned in a central artery of the patient.

12 . The apparatus of claim 9 , wherein the instructions are further configured to cause the electronic circuitry to, based on a heart rate included in the electrophysiological response, adjust the characteristic of the electrical stimulation.

13 . The apparatus of claim 12 , wherein the instructions are further configured to cause the electronic circuitry to detect the heart rate of the patient.

14 . The apparatus of claim 9 , wherein the instructions are further configured to cause the electronic circuitry to, based on the detected electrophysiological response, adjust a pacing rate of the electrical stimulation to achieve or maintain rapid pacing of the heart.

15 . The apparatus of claim 9 , wherein the instructions are further configured to cause the electronic circuitry to, based on the detected electrophysiological response, adjust the pacing rate of the electrical stimulation to achieve or maintain to drop a blood pressure or a cardiac output of the heart of the patient below a threshold amount.

16 . The apparatus of claim 15 , wherein the instructions are further configured to cause the electronic circuitry to set the threshold amount of the blood pressure of the cardiac output to facilitate safe balloon deployment to the heart.

17 . A method comprising:

delivering, via an electrical pulse generator, electrical stimulation through a guidewire to an electrode positioned on or spaced from a ventricular wall of a heart of a patient, wherein the guidewire comprises an elongated body extending from a proximal end portion to a distal end portion and having an intermediate portion therebetween, the distal end portion including the electrode;

detecting, at the electrical pulse generator, an electrophysiological response in response to delivery of the electrical stimulation; and

based on the detected electrophysiological response, adjusting a characteristic of the electrical stimulation to achieve or maintain rapid pacing of the heart, wherein the proximal end portion and the intermediate portion are configured to support delivery and accurate positioning placement of a treatment device to the heart while the electrical pulse generator maintains the rapid pacing of the heart.

18 . The method of claim 17 , further comprising, based on a pulse pressure and/or a systolic blood pressure, adjusting the characteristic of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

19 . The method of claim 18 , further comprising detecting the pulse pressure and/or the systolic blood pressure via a pressure monitor positioned in a central artery of the patient.

20 . The method of claim 17 , further comprising, based on a heart rate included in the electrophysiological response, adjusting the characteristic of the electrical stimulation to achieve or maintain the rapid pacing of the heart.

21 . The method of claim 20 , further comprising detecting the heart rate of the patient.

22 . The method of claim 17 , further comprising, based on the detected electrophysiological response, adjusting a pacing rate of the electrical stimulation to achieve or maintain rapid pacing of the heart.

23 . The method of claim 17 , further comprising, based on the detected electrophysiological response, adjusting the pacing rate of the electrical stimulation to achieve or maintain to drop a blood pressure or a cardiac output of the heart of the patient below a threshold amount.

24 . The method of claim 23 , further comprising selecting the threshold amount of the blood pressure of the cardiac output to facilitate safe balloon deployment to the heart.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066617/0582 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066621/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0565 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0817 →
CHANGE OF NAME Recorded Aug 10, 2023
From: VASCULAR SOLUTIONS, INC.
To: VASCULAR SOLUTIONS LLC
Reel/Frame 064560/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: KUGLER, CHAD; BRIDGEMAN, JOHN; STRATTON, DEREK; PETERSON, DEAN; BRENIZER, JOSHUA
To: VASCULAR SOLUTIONS, INC.
Reel/Frame 064550/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: DANIELS, DAVID
To: CARDIAC INTERVENTIONS AND AVIATION LLC
Reel/Frame 064561/0192 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: VASCULAR SOLUTIONS LLC
To: TELEFLEX INNOVATIONS S.À.R.L.
Reel/Frame 064559/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: TELEFLEX INNOVATIONS S.À.R.L.
To: TELEFLEX MEDICAL DEVICES S.À.R.L.
Reel/Frame 064559/0636 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: TELEFLEX MEDICAL DEVICES S.À.R.L.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 064559/0717 →
Continuity (9)
Continuation 17811892 · Jul 12, 2022
Continuation 16936738 · Jul 23, 2020
Continuation 16214800 · Dec 10, 2018
Continuation 15455265 · Mar 10, 2017
Provisional Application 62436750 · Dec 20, 2016
Provisional Application 62378258 · Aug 23, 2016
Provisional Application 62346214 · Jun 6, 2016
Provisional Application 62310044 · Mar 18, 2016
Related Publication 20230390552A1 · Dec 7, 2023
References Cited (113)
US 3769984A · Muench · 1973 [cited by applicant]
US 4497326A · Curry · 1985 [cited by applicant]
US 4917102A · Miller et al. · 1990 [cited by applicant]
US 4957110A · Vogel et al. · 1990 [cited by applicant]
US 5143089A · Alt · 1992 [cited by applicant]
US 5190052A · Schroeppel · 1993 [cited by applicant]
US 5228453A · Sepetka · 1993 [cited by applicant]
US 5354327A · Smits · 1994 [cited by applicant]
US 5379779A · Rowland et al. · 1995 [cited by applicant]
US 5609622A · Soukup et al. · 1997 [cited by applicant]
US 5807339A · Bostrom et al. · 1998 [cited by applicant]
US 5824030A · Yang et al. · 1998 [cited by applicant]
US 5902331A · Bonner et al. · 1999 [cited by applicant]
US 6106488A · Fleming et al. · 2000 [cited by applicant]
US 6161029A · Spreigl et al. · 2000 [cited by applicant]
US 6301507B1 · Bakels et al. · 2001 [cited by applicant]
US 6356791B1 · Westlund et al. · 2002 [cited by applicant]
US 6978185B2 · Osypka · 2005 [cited by applicant]
US 6999821B2 · Jenney et al. · 2006 [cited by applicant]
US 7094294B2 · Shiota · 2006 [cited by applicant]
US 7225035B2 · Brabec et al. · 2007 [cited by applicant]
US 7381205B2 · Thommen · 2008 [cited by applicant]
US 7702392B2 · Echt et al. · 2010 [cited by applicant]
US 7715903B2 · Hartley et al. · 2010 [cited by applicant]
US 7785273B2 · Eskuri · 2010 [cited by applicant]
US 7918947B2 · Kato · 2011 [cited by applicant]
US 8639341B2 · Sommer et al. · 2014 [cited by applicant]
US 8945208B2 · Jimenez et al. · 2015 [cited by applicant]
US 9031647B2 · Maskara et al. · 2015 [cited by applicant]
US 9295813B2 · Kanazawa et al. · 2016 [cited by applicant]
US 9387323B2 · Fleischhacker et al. · 2016 [cited by applicant]
US 9446219B2 · Lupton · 2016 [cited by applicant]
US 10173052B2 · Daniels et al. · 2019 [cited by applicant]
US 10758725B2 · Daniels et al. · 2020 [cited by applicant]
US 10881851B2 · Daniels et al. · 2021 [cited by applicant]
US 11420046B2 · Daniels et al. · 2022 [cited by applicant]
US 20020002329A1 · Avitall · 2002 [cited by applicant]
US 20020049476A1 · Bardy · 2002 [cited by examiner]
US 20020049485A1 · Smits · 2002 [cited by applicant]
US 20020193836A1 · Schmidt · 2002 [cited by applicant]
US 20030050681A1 · Pianca et al. · 2003 [cited by applicant]
US 20030109914A1 · Westlund et al. · 2003 [cited by applicant]
US 20030114777A1 · Griffin et al. · 2003 [cited by applicant]
US 20030125780A1 · Belden · 2003 [cited by applicant]
US 20030212446A1 · Kaplan et al. · 2003 [cited by applicant]
US 20040024425A1 · Worley et al. · 2004 [cited by applicant]
US 20040064172A1 · McVenes et al. · 2004 [cited by applicant]
US 20040260374A1 · Zhang et al. · 2004 [cited by applicant]
US 20050027343A1 · Westlund et al. · 2005 [cited by applicant]
US 20050033136A1 · Govari et al. · 2005 [cited by applicant]
US 20060009828A1 · Bemurat et al. · 2006 [cited by applicant]
US 20060036306A1 · Heist et al. · 2006 [cited by applicant]
US 20060106445A1 · Woollett · 2006 [cited by applicant]
US 20060135953A1 · Kania et al. · 2006 [cited by applicant]
US 20060259063A1 · Bates et al. · 2006 [cited by applicant]
US 20070060961A1 · Echt et al. · 2007 [cited by applicant]
US 20090005846A1 · Zhu et al. · 2009 [cited by applicant]
US 20090270941A1 · Mokelke et al. · 2009 [cited by applicant]
US 20090318992A1 · Eidenschink et al. · 2009 [cited by applicant]
US 20100057072A1 · Roman et al. · 2010 [cited by applicant]
US 20100228330A1 · Bornzin · 2010 [cited by applicant]
US 20100318172A1 · Schaefer · 2010 [cited by applicant]
US 20110071608A1 · Fleischhacker et al. · 2011 [cited by applicant]
US 20110306867A1 · Gopinathan et al. · 2011 [cited by applicant]
US 20120016342A1 · Brecker · 2012 [cited by applicant]
US 20120065624A1 · Matsukuma et al. · 2012 [cited by applicant]
US 20120130220A1 · Maskara et al. · 2012 [cited by applicant]
US 20120130397A1 · Reddy et al. · 2012 [cited by applicant]
US 20130178908A1 · Huber · 2013 [cited by applicant]
US 20130325086A1 · Sommer et al. · 2013 [cited by applicant]
US 20140066895A1 · Kipperman · 2014 [cited by applicant]
US 20140172035A1 · Shuros et al. · 2014 [cited by applicant]
US 20140330366A1 · Dehdashtian et al. · 2014 [cited by applicant]
US 20150032027A1 · Lupton · 2015 [cited by applicant]
US 20150051696A1 · Hou et al. · 2015 [cited by applicant]
US 20150290432A1 · Mathews et al. · 2015 [cited by applicant]
US 20160029960A1 · Toth et al. · 2016 [cited by applicant]
US 20160228013A1 · Al-Jilaihawi et al. · 2016 [cited by applicant]
US 20170266433A1 · Daniels et al. · 2017 [cited by applicant]
US 20170266434A1 · Daniels et al. · 2017 [cited by applicant]
US 20170281910A1 · Whisenant et al. · 2017 [cited by applicant]
US 20190105490A1 · Daniels et al. · 2019 [cited by applicant]
US 20200030583A1 · Martin et al. · 2020 [cited by applicant]
US 20200353241A1 · Daniels et al. · 2020 [cited by applicant]
US 20220339432A1 · Daniels et al. · 2022 [cited by applicant]
CN 102711902A · 2012 [cited by applicant]
DE 202010011542U1 · 2010 [cited by applicant]
DE 102011109880 · 2013 [cited by applicant]
EP 0109178B1 · 1992 [cited by applicant]
EP 1561489A2 · 2005 [cited by applicant]
EP 1208867B1 · 2010 [cited by applicant]
EP 2480282B1 · 2015 [cited by applicant]
JP 2013505781A · 2013 [cited by applicant]
WO 1998036794A1 · 1998 [cited by applicant]
WO 2008011261A2 · 2008 [cited by applicant]
WO 2008051554A2 · 2008 [cited by applicant]
WO 2011037978A2 · 2011 [cited by applicant]
“Office Action” mailed Jul. 1, 2024, in co-pending U.S. Appl. No. 17/811,892. [cited by applicant]
Response to Office Action filed Oct. 1, 2024, in co-pending U.S. Appl. No. 17/811,892. [cited by applicant]
Aliyev, Farid, et al. “Perforations of right heart chambers associated with electrophysiology catheters and temporary transvenous pacing leads.” Turk Kardiyol Dern Ars, 2011, 39(1): 16-22. [cited by applicant]
Banaszewski, Marek, et al. “Right heart perforation by pacemaker leads.” Arch Med Sci, 2012, 8(1): 11-13. [cited by applicant]
European Extended Search Report and Opinion mailed Jul. 14, 2021 in EP Application No. 21169704.0. [cited by applicant]
Guerios, Enio E. et al. “Left Ventricular Guidewire Pacing for Transcatheter Aortic Valve Implantation,” Catheterization and Cardiovascular Interventions, 82, pp. E919-E921 (2013). [cited by applicant]
Holmes Jr., David R., et al. “Iatrogenic Pericardial Effusion and Tamponade in the Percutaneous Intracardiac Intervention Era,” JACC Cardiovasc Interv, 2009, 2(8): 705-17. [cited by applicant]
Navarini, Susanne et al. “Left Ventricular Guidewire Pacing to Simplify Aortic Balloon Valvuloplasty,” Catheterization and Cardiovascular Interventions, 73: 426-427 (2009). [cited by applicant]
PCT 2nd Written Opinion mailed Dec. 7, 2017 in application PCT/US2017/021719 filed Mar. 10, 2017. [cited by applicant]
PCT Article 34 amendments filed Jul. 20, 2017 in connection with application No. PCT/US2017/021719 filed Mar. 10, 2017. [cited by applicant]
PCT International Preliminary Report on Patentability mailed Feb. 2, 2018 in application PCT/US2017/021719 filed Mar. 10, 2017. [cited by applicant]
PCT International Search Report mailed May 11, 2017 in application PCT/US2017/021719 filed Mar. 10, 2017. [cited by applicant]
PCT Written Opinion mailed May 11, 2017 in application PCT/US2017/021719 filed Mar. 10, 2017. [cited by applicant]
Final Office Action mailed Oct. 23, 2024 in U.S. Appl. No. 17/811,892. [cited by applicant]
Response to Final Office Action filed Jan. 23, 2025 in U.S. Appl. No. 17/811,892. [cited by applicant]
Notice of Allowance mailed May 29, 2025 in U.S. Appl. No. 17/811,892. [cited by applicant]